Tax1bp1-deficiency decreases the frequency of microabscess formation and lymphocyte depletion during <i>L. monocytogenes</i> infection. حسب Jeffrey Chin (22538086)

Pre-RT and post RT D-dimer levels in associated with prognostic significance. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

The inhibitory activity of the most active compounds against Glo-I enzyme with less than 50 µM. Their supportive corresponding docking values on two different protocols are display... حسب MohammedBashar Al-Qazzan (22439236)

The effect of pre-RT D-dimer levels on post-RT changes in D-dimer levels and on survival rates. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

ROC curve according to their D-dimer values in patients with PFS ≥ 1 year and those with PFS < 1 year. p < 0.001 (95% CI: 4-21). حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Kaplan Meier curves of OS and PFS according to RT and/or CRT response. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Univariate and multivariable analyses for progression free survival. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Kaplan Meier curves of OS and PFS according to different pre-RT different D-dimer values. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Univariate and multivariable analyses for OS. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Characteristics of LC patients. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Decision curve analysis according to t D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Kaplan Meier curves of OS and PFS according to d-dimer values comparing OS rates between patients with D-dimer levels ≤ 0.3 µg/mL and those with levels > 0.3 µg/mL. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

ROC curve according to their D-dimer values in patients with OS ≥ 1 year and those with OS < 1 year. p < 0.001 (95% CI: 6-24). حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Flowchart of this study. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

RT characteristics and D-dimer, OS and PFS of patients. حسب Huriye Senay Kiziltan (22298378)

الموضوعات:

Combination of intraperitoneal and intratumoral administration of vitamin D3 is more effective in reducing the EAC tumor volume compared to just i.p. administration: حسب Vidya G. Bettada (22208808)

"…Administration of cisplatin (2.5 mg/Kg) and vitamin D3 (125 µg/Kg) significantly decreased the vessel density (CD31) compared to the tumor control group.…"

Mice in the NTC and MBC-005 treatment groups were evaluated for bioluminescent signaling at 6-, 13-, and 21-days after tumor inoculation. حسب Bryan S. Margulies (21492667)

Study data. حسب Jie Liu (15128)

"…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…"

Summary of clinical outcomes after 9 months. حسب Jie Liu (15128)

"…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…"

Approval by the research ethics committee. حسب Jie Liu (15128)

"…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…"